Transvenous carotid body ablation for resistant hypertension: main results of a multicentre safety and proof-of-principle cohort study

M. Schlaich, C. Schultz, S. Shetty, D. Hering, S. Worthley, S. Delacroix, V. Reddy, H. Sievert, T. Zeller, E. Noory, M. Boehm, F. Mahfoud, F. Malek, P. Kmonicek, P. Neuzil

Research output: Contribution to journalAbstract/Meeting Abstract

Original languageEnglish
Pages (from-to)267-267
Number of pages1
JournalEuropean Heart Journal
Volume39
Publication statusPublished - Aug 2018
EventEuropean Society of Cardiology Congress - Messe München Congress Centre, Munich, Germany
Duration: 25 Aug 201829 Aug 2018
https://www.escardio.org/Congresses-&-Events/ESC-TV/ESC-Congress-2018 (Congress website)

Cite this

Schlaich, M., Schultz, C., Shetty, S., Hering, D., Worthley, S., Delacroix, S., Reddy, V., Sievert, H., Zeller, T., Noory, E., Boehm, M., Mahfoud, F., Malek, F., Kmonicek, P., & Neuzil, P. (2018). Transvenous carotid body ablation for resistant hypertension: main results of a multicentre safety and proof-of-principle cohort study. European Heart Journal, 39, 267-267.